Form 15-12B - Securities registration termination [Section 12(b)]:
SEC Accession No. 0000950103-19-017784
Filing Date
2019-12-27
Accepted
2019-12-27 14:11:37
Documents
1
Effectiveness Date
2019-12-27

Document Format Files

Seq Description Document Type Size
1 FORM 15-12B dp117868_1512b.htm 15-12B 10669
  Complete submission text file 0000950103-19-017784.txt   11713
Mailing Address 3737 MARKET STREET SUITE 1300 PHILADELPHIA PA 19104
Business Address 3737 MARKET STREET SUITE 1300 PHILADELPHIA PA 19104 888-772-7560
Spark Therapeutics, Inc. (Filer) CIK: 0001609351 (see all company filings)

EIN.: 462654405 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 15-12B | Act: 34 | File No.: 001-36819 | Film No.: 191313279
SIC: 2836 Biological Products, (No Diagnostic Substances)